Announcement PDF Emyria Limited ACN 625 085 734 Notice of General Meeting Time and date: Wednesday, 21 August 2024 at 2.00pm (AWST) Location: At the offices of Stantons International, Level 2, 40 Kings Park Road, West Perth, WA, Australia The Notice of General Meeting should be read in its entirety. If Shareholders are in doubt as to how to vote, they should seek advice from their suitably qualified advisor prior to voting. Should you wish to discuss any matter, please do not hesitate to contact the Company Secretary by telephone on +61 8 6559 2800. Shareholders are urged to vote by lodging the Proxy Form Emyria Limited ACN 625 085 734 (Company) Notice of General Meeting Notice is hereby given that a general meeting of Shareholders of Emyria Limited will be held at the offices of Stantons International, Level 2, 40 Kings Park Road, West Perth, WA, Australia at 2.00pm (AWST) on Wednesday, 21 August 2024 (AWST) (Meeting). The Explanatory Memorandum provides additional information on matters to be considered at the Meeting. The Explanatory Memorandum and the Proxy Form form part of the Notice. The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered as Shareholders on Monday, 19 August 2024 at 5.00pm (AWST). Terms and abbreviations used in the Notice are defined in Schedule 1. Agenda 1 Resolutions Resolution 1 – Ratification of issue of Placement Shares To consider and, if thought fit, to pass with or without amendment, each as a separate ordinary resolution the following: ‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of: (a) 2,937,061 Placement Shares issued under Listing Rule 7.1; and (b) 36,662,939 Placement Shares issued under Listing Rule 7.1A, on the terms and conditions in the Explanatory Memorandum.’ Resolution 2 – Ratification of issue of Placement Options To consider and, if thought fit, to pass without or without amendment, as an ordinary resolution the following: ‘That, pursuant to and in accordance with Listing Rule 7.4, and for all other purposes, Shareholders ratify the issue of 19,800,000 Placement Options under Listing Rule 7.1, on the terms and conditions in the Explanatory Memorandum.’ Page 2 Resolution 3 – Approval of issue of Director Placement Securities To consider and, if thought fit, to pass with or without amendment, each as a separate ordinary resolution the following: ‘That, pursuant to and in accordance with Listing Rule 10.11, section 195(4) of the Corporations Act and for all other purposes, Shareholders approve the issue of 9,600,000 Director Placement Securities to the Directors (and/or their respective nominees) as follows: (a) up to 6,000,000 Director Placement Shares and 3,000,000 Director Placement Options to Greg Hutchinson; and (b) up to 400,000 Director Placement Shares and 200,000 Director Placement Options to Michael Winlo, on the terms and conditions in the Explanatory Memorandum.’ Resolution 4 – Ratification of issue of Lead Manager Shares To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: ‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 2,760,000 Shares issued under Listing Rule 7.1 to Sixty Two Capital Pty Ltd (or its respective nominee) as follows on the terms and conditions in the Explanatory Memorandum.’ Resolution 5 – Ratification of issue of Lead Manager Options To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: ‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 3,380,000 Options issued under Listing Rule 7.1 to Sixty Two Capital Pty Ltd (or its respective nominees) as follows on the terms and conditions in the Explanatory Memorandum.’ Voting exclusions Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of: (a) Resolution 1(a): by or on behalf of a person who participated in the issue of the Placement Shares issued under Listing Rule 7.1, or any of their respective associates. (b) Resolution 1(b): by or on behalf of a person who participated in the issue of the Placement Shares issued under Listing Rule 7.1A, or any of their respective associates. (c) Resolution 2: by or on behalf of a person who participated in the issue of the Placement Options, or any of their respective associates. (d) Resolution 3(a): by or on behalf of Greg Hutchinson (or his nominees), and any other person who will obtain a material benefit as a result of the issue of these Director Placement Page 3 Securities (except a benefit solely by reason of being a Shareholder), or any of their respective associates. (e) Resolution 3(b): by or on behalf of Michael Winlo (or his nominees), and any other person who will obtain a material benefit as a result of the issue of these Director Placement Securities (except a benefit solely by reason of being a Shareholder), or any of their respective associates. (f) Resolution 4: by or on behalf of Sixty Two Capital Pty Ltd (or its respective nominees), or an associate of Sixty Two Capital Pty Ltd (or its respective nominees). (g) Resolution 5: by or on behalf of Sixty Two Capital Pty Ltd (or its respective nominees), or an associate of Sixty Two Capital Pty Ltd (or its respective nominees). The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution by: (a) a person as proxy or attorney for a person who is entitled to vote, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; (b) the Chair as proxy or attorney for a person who is entitled to vote, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way. BY ORDER OF THE BOARD Susan Park Company Secretary Emyria Limited Dated: 19 July 2024 Page 4 Emyria Limited ACN 625 085 734 (Company) Explanatory Memorandum 1. Introduction The Explanatory Memorandum has been prepared for the information of Shareholders in connection with the business to be conducted at the Meeting to be held at the offices of Stantons International, Level 2, 40 Kings Park Road, West Perth, WA, Australia on Wednesday, 21 August 2024 at 2.00pm (AWST). The Explanatory Memorandum forms part of the Notice which should be read in its entirety. The Explanatory Memorandum contains the terms and conditions on which the Resolution will be voted. The Explanatory Memorandum includes the following information to assist Shareholders in deciding how to vote on the Resolution: Section 2 Action to be taken by Shareholders Section 3 Resolution 1(a) and (b) – Ratification of issue of Placement Shares Section 4 Resolution 2 – Ratification of issue of Placement Options Section 5 Resolution 3(a) and (b) – Approval of issue of Director Placement Securities Section 6 Resolution 4 – Ratification of issue of Lead Manager Shares Section 7 Resolution 5 – Ratification of issue of Lead Manager Options Schedule 1 Definitions Schedule 2 Terms and conditions of Options A Proxy Form is located at the end of the Explanatory Memorandum. Page 5 2. Action to be taken by Shareholders Shareholders should read the Notice including the Explanatory Memorandum carefully before deciding how to vote on the Resolution. 2.1 Voting in person To vote in person, attend the Meeting on the date and at the place set out above. 2.2 Voting by proxy A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited and encouraged to attend the Meeting or, if they are unable to attend in person, sign and return the Proxy Form to the Company in accordance with the instructions thereon. Lodgement of a Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in person. Please note that: (a) a member of the Company entitled to attend and vote at the Meeting is entitled to appoint a proxy; (b) a proxy need not be a member of the Company; and (c) a member of the Company entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise, but where the proportion or number is not specified, each proxy may exercise half of the votes. The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy Forms. Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify the way the proxy is to vote on a particular resolution and, if it does: (a) the proxy need not vote on a show of hands, but if the proxy does so, the proxy must vote that way (i.e. as directed); (b) if the proxy has 2 or more appointments that specify different ways to vote on the resolution – the proxy must not vote on a show of hands; (c) if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy must vote on a poll, and must vote that way (i.e. as directed); and (d) if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does so, the proxy must vote that way (i.e. as directed). Section 250BC of the Corporations Act provides that, if: (a) an appointment of a proxy specifies the way the proxy is to vote on a particular resolution at a meeting of the Company's members; (b) the appointed proxy is not the chair of the meeting; Page 6 (c) at the meeting, a poll is duly demanded, or is otherwise required under section 250JA on the resolution; and (d) either the proxy is not recorded as attending the meeting or the proxy does not vote on the resolution, the Chair of the meeting is taken, before voting on the resolution closes, to have been appointed as the proxy for the purposes of voting on the resolution at the meeting. Your proxy voting instruction must be received by 2.00pm (AWST) on Monday, 19 August 2024, being not later than 48 hours before the commencement of the Meeting. 2.3 Chair's voting intentions The Chair intends to exercise all available proxies in favour of all Resolutions, unless the Shareholder has expressly indicated a different voting intention. 2.4 Submitting questions Shareholders may submit questions in advance of the Meeting to the Company. Questions must be submitted by emailing the Company Secretary at info@emyria.com by 9.00am (AWST) on Monday, 19 August 2024. Shareholders will also have the opportunity to submit questions during the Meeting in respect to the formal items of business. In order to ask a question during the Meeting, please follow the instructions from the Chair. The Chair will attempt to respond to the questions during the Meeting. The Chair will request prior to a Shareholder asking a question that they identify themselves (including the entity name of their shareholding and the number of Shares they hold). 3. Resolution 1(a) and (b) – Ratification of issue of Placement Shares 3.1 Background On 23 April 2024, the Company announced that it had secured firm commitments from new and existing professional and sophisticated investors to raise approximately $2,300,000 (before costs) via a two-tranche placement (Placement). The Placement is comprised of an aggregate 46,000,000 Shares at an issue price of $0.05 per Share, with one (1) free attaching unquoted Option for every two (2) Shares issued, each exercisable at $0.10 each and expiring 3 years from the date of issue, as follows: 3.2 (a) 39,600,000 Shares to be issued to unrelated professional and sophisticated investors (the subject of Resolution 1(a) and (b)) (Placement Shares) and 19,800,000 unquoted Options (the subject of Resolution 2) (Placement Options); and (b) 6,400,000 Shares (Director Placement Shares) and 3,200,000 unquoted Options (Director Placement Options) proposed to be issued to Directors Greg Hutchinson and Michael Winlo (and/or their respective nominees) (the subject of Resolution 3). General On 7 May 2024, the Company issued the Placement Shares as follows: Page 7 (a) 2,937,061 Placement Shares using the Company’s available placement capacity under Listing Rule 7.1; and (b) 36,662,939 Placement Shares using the Company’s available placement capacity under Listing Rule 7.1A. Resolution 1(a) and (b) seek the approval of Shareholders pursuant to Listing Rule 7.4 to ratify the issue of the Placement Shares. 3.3 Listing Rules 7.1, 7.1A and 7.4 Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary shares it had on issue at the start of that period. Under Listing Rule 7.1A, an eligible entity can seek approval from its members, by way of a special resolution passed at its annual general meeting, to increase its 15% placement capacity under Listing Rule 7.1 by an extra 10% to 25%. The Company obtained this approval at its annual general meeting held on 16 November 2023. The issue of the Placement Shares does not fit within any of the exceptions to Listing Rules 7.1 and 7.1A and, as it has not yet been approved by Shareholders, effectively uses up part of the Company's placement capacities under Listing Rules 7.1 and 7.1A. This reduces the Company's capacity to issue further Equity Securities without Shareholder approval under Listing Rules 7.1 and 7.1A for the 12 month period following the issue of the Placement Shares. Listing Rule 7.4 provides an exception to Listing Rules 7.1 and 7.1A. It provides that where a company in a general meeting ratifies the previous issue of securities made pursuant to Listing Rules 7.1 and 7.1A (and provided that the previous issue did not breach Listing Rules 7.1 and 7.1A), those Equity Securities will be deemed to have been made with shareholder approval for the purpose of Listing Rules 7.1 and 7.1A. The effect of Shareholders passing Resolution 1(a) and (b) will be to allow the Company to retain the flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in Listing Rule 7.1 and the 10% additional placement capacity set out in Listing Rule 7.1A without the requirement to obtain prior Shareholder approval. If Resolution 1(a) is passed, 2,937,061 Placement Shares will be excluded in calculating the Company's 15% limit in Listing Rule 7.1, effectively increasing the number of Equity Securities it can issue without Shareholder approval over the 12 month period following the issue date. If Resolution 1(b) is passed, 36,662,939 Placement Shares will be excluded in calculating the Company's 10% limit in Listing Rule 7.1A, effectively increasing the number of Equity Securities it can issue without Shareholder approval over the 12 month period following the issue date. If Resolution 1(a) is not passed, 2,937,061 Placement Shares will continue to be included in the Company's 15% limit under Listing Rule 7.1, effectively decreasing the number of Equity Securities the Company can issue or agree to issue without obtaining prior Shareholder approval, to the extent of 2,937,061 Equity Securities for the 12 month period following the issue of those Placement Shares. Page 8 If Resolution 1(b) is not passed, 36,662,939 Placement Shares will continue to be included in the Company's 10% limit under Listing Rule 7.1A, effectively decreasing the number of Equity Securities the Company can issue or agree to issue without obtaining prior Shareholder approval, to the extent of 36,662,939 Equity Securities for the 12 month period following the issue of those Placement Shares (and assuming the Company's approval under Listing Rule 7.1A remains in force for this period). 3.4 Specific information required by Listing Rule 7.5 Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in relation to the ratification of the issue of the Placement Shares: 3.5 (a) The Placement Shares were issued to sophisticated and institutional investors (Placement Participants), none of whom is a related party or Material Investor of the Company. The participants in the Placement were identified through a bookbuild process, which involved the Lead Manager seeking expressions of interest to participate in the Placement from existing contacts of the Company and clients of the Lead Manager. (b) A total of 39,600,000 Placement Shares were issued as follows: (i) 2,937,061 Shares were issued using the Company’s available placement capacity under Listing Rule 7.1; and (ii) 36,662,939 Shares were issued using the Company’s available placement capacity under Listing Rule 7.1A. (c) The Placement Shares are fully paid ordinary shares in the capital of the Company and rank equally in all respects with the Company's existing Shares on issue. (d) The Placement Shares were issued on 7 May 2024 at $0.05 per Share. (e) The proceeds from the issue of the Placement Shares have been or are intended to be applied towards: (i) support the strategic scale-up and national expansion of the Empax Centre; (ii) costs of the Placement; and (iii) general working capital. (f) There are no other material terms to the agreement for the subscription of the Placement Shares. (g) A voting exclusion statement is included in the Notice. Additional information Resolution 1(a) and (b) are each separate ordinary resolutions. The Board recommends that Shareholders vote in favour of Resolution 1(a) and (b). Page 9 4. Resolution 2 – Ratification of issue of Placement Options 4.1 General The background to the issue of the Placement Options is in Section 3.1 above. On 7 May 2024, the Company issued the Placement Options using the Company's available placement capacity under Listing Rule 7.1. Resolution 2 seeks Shareholder approval pursuant to Listing Rule 7.4 to ratify the issue of the Placement Options. 4.2 Listing Rule 7.1 and 7.4 A summary of Listing Rules 7.1 and 7.4 is contained in Section 3.3 above. The issue of the Placement Options does not fit within any of the exceptions to Listing Rule 7.1 and, as it has not yet been approved by Shareholders, effectively uses up part of the Company's placement capacity under Listing Rule 7.1. This reduces the Company's capacity to issue further Equity Securities without Shareholder approval under Listing Rule 7.1 for the 12-month period following the issue of the Placement Options. The effect of Shareholders passing Resolution 2 will be to allow the Company to retain the flexibility to issue Equity Securities in the future up to the 15% additional placement capacity set out in Listing Rule 7.1 without the requirement to obtain prior Shareholder approval. If Resolution 2 is passed, 19,800,000 Placement Options will be excluded in calculating the Company's 15% limit in Listing Rule 7.1, effectively increasing the number of Equity Securities it can issue without Shareholder approval over the 12-month period following the issue date. If Resolution 2 is not passed, 19,800,000 Placement Options will continue to be included in the Company's 15% limit under Listing Rule 7.1, effectively decreasing the number of Equity Securities the Company can issue or agree to issue without obtaining prior Shareholder approval, to the extent of 19,800,000 Equity Securities for the 12 month period following the issue of the Placement Options. 4.3 Specific information required by Listing Rule 7.5 Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in relation to the ratification of the issue of the Placement Options: (a) The Placement Options were issued to the Placement Participants (refer to Section 3.4(a) above for further details of the Placement Participants). (b) A total of 19,800,000 Placement Options were issued using the Company’s available placement capacity under Listing Rule 7.1, without the need for Shareholder approval. (c) The 19,800,000 Placement Options were issued on 7 May 2024. (d) The Placement Options were issued as free-attaching Options to the Placement Shares. Accordingly, nil additional cash consideration was payable by the Placement Participants. (e) The Placement Options are exercisable at $0.10 each, expiring 7 May 2027, and are otherwise subject to the terms and conditions in Schedule 2. Shares issued upon Page 10 exercise of the Placement Options will be fully paid ordinary Shares in the capital of the Company and will rank equally in all respects with the Company's existing Shares on issue. 4.4 (f) A summary of the intended use of funds raised from the Placement is in Section 3.4(e) above. No additional funds will be raised by the issue of the Placement Options. Any funds raised upon exercise of the Placement Options will be used towards general working capital purposes. (g) There are no other material terms to the issue of the Placement Options. (h) A voting exclusion statement is included in the Notice. Additional information Resolution 2 is an ordinary resolution. The Board recommends that Shareholders vote in favour of Resolution 2. 5. Resolution 3(a) and (b) – Approval of issue of Director Placement Securities 5.1 General The background to the Placement is in Section 3.1 above. Directors Greg Hutchinson and Michael Winlo wish to participate in the Placement to the extent of subscribing for up to 6,400,000 Director Placement Shares and 3,200,000 Director Placement Options (together, the Director Placement Securities) to raise up to approximately $320,000 (before costs) in the following proportions: Director Amount committed to the Placement Director Placement Shares Director Placement Options Greg Hutchinson $300,000 6,000,000 3,000,000 Michael Winlo $20,000 400,000 200,000 TOTAL $320,000 6,400,000 3,200,000 Resolution 3(a) - (b) (inclusive) seek Shareholder approval pursuant to Listing Rule 10.11 for the issue of the Director Placement Securities to the Directors (or their respective nominees). 5.2 Listing Rule 10.11 Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a listed company must not issue or agree to issue Equity Securities to any of the following persons without the approval of its Shareholders: Page 11 (a) a related party (Listing Rule 10.11.1); (b) a person who is, or was at any time in the 6 months before the issue or agreement, a substantial holder (30%+) in the company (Listing Rule 10.11.2); (c) a person who is, or was at any time in the 6 months before the issue or agreement, a substantial holder (10%+) in the company and who has nominated a director to the board of the company pursuant to a relevant agreement which gives them a right or expectation to do so (Listing Rule 10.11.3); (d) an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3 (Listing Rule 10.11.4); or (e) a person whose relation with the company or a person referred to in Listing Rule 10.11.1 or 10.11.4 is such that, in ASX's opinion, the issue or agreement should be approved by its shareholders (Listing Rule 10.11.5). The Directors are each a related party of the Company by virtue of being Directors. Shareholder approval pursuant to Listing Rule 10.11 is therefore required unless an exception applies. It is the view of the Board that the exceptions set out in Listing Rule 10.12 do not apply in the current circumstances. Approval pursuant to Listing Rule 7.1 is not required for the issue of the Director Placement Securities as approval is being obtained under Listing Rule 10.11. Accordingly, the issue of the Director Placement Securities to the Directors (or their respective nominees) will not be included in the Company's 15% annual placement capacity pursuant to Listing Rule 7.1. The effect of Shareholders passing Resolution 3(a) to (b) (inclusive) will be to allow the Company to issue the Director Placement Securities, raising up to $320,000 (before costs). If Resolution 3(a) - (b) (inclusive) are not passed, the Company will not be able to proceed with the issue of the Director Placement Securities and will not receive the additional $320,000 (before costs) committed by the Directors. 5.3 Specific information required by Listing Rule 10.13 Pursuant to and in accordance with Listing Rule 10.13, the following information is provided in relation to the proposed issue of the Director Placement Securities: (a) The Director Placement Securities will be issued to the Directors (or their respective nominees) in the manner set out in Section 5.1. (b) Each of the Directors fall into the category stipulated by Listing Rule 10.11.1 by virtue of being Directors of the Company. (c) A maximum of 6,400,000 Director Placement Shares and 3,200,000 Director Placement Options will be issued to the Directors (and/or their respective nominees). (d) The Director Placement Shares will be fully paid ordinary Shares in the capital of the Company and rank equally in all respects with the Company's existing Shares on issue. (e) The Director Placement Options will be exercisable at $0.10 each and will expire on 7 May 2027. The Director Placement Options are subject to the terms and conditions Schedule 2. Page 12 5.4 (f) The Director Placement Securities will be issued within one month after the date of the Meeting. (g) The Director Placement Shares are proposed to be issued at an issue price of $0.05 each, being the same issue price as other Placement Shares and will raise up to approximately $320,000 (before costs). (h) The Director Placement Options are proposed to be issued for nil cash consideration as they are free-attaching to the Director Placement Shares. Accordingly, no funds will be raised from the issue of the Director Placement Options. Any funds raised upon exercise of the Director Placement Options will be used towards general working capital purposes. (i) A summary of the intended use of funds raised from the Placement is in Section 3.4(e) above. No additional funds will be raised by the issue of the Director Placement Options. (j) The proposed issue of the Director Placement Securities is not intended to remunerate or incentivise the Directors. (k) There are no other material terms to the proposed issue of the Director Placement Securities. The Director Placement Securities will not be issued pursuant to an agreement. (l) A voting exclusion statement is included in the Notice. Section 195 of the Corporations Act Section 195(1) of the Corporations Act prohibits a director of a public company who has a material personal interest in a matter that is being considered at a meeting of directors from being present while the matter is being considered at the meeting or voting on the matter. If there is not a quorum of directors who are eligible to vote on a matter because of the operation of section 195(1) of the Corporations Act, one or more directors may call a general meeting and the general meeting may deal with the matter. The Directors have a personal interest in the outcome of Resolution 3(a) - (b) (inclusive) and have exercised their right under section 195(4) of the Corporations Act to put the issue of the Director Placement Securities to Shareholders to resolve. 5.5 Chapter 2E of the Corporations Act In accordance with Chapter 2E of the Corporations Act, in order to give a financial benefit to a related party, the Company must: (a) obtain Shareholder approval in the manner set out in section 217 to 227 of the Corporations Act; and (b) give the benefit within 15 months following such approval, unless the giving of the financial benefit falls within an exception set out in sections 210 to 216 of the Corporations Act. The proposed issue of the Director Placement Securities constitutes giving a financial benefit to related parties of the Company. Page 13 The Board considers that Shareholder approval pursuant to Chapter 2E of the Corporations Act is not required in respect of the issue of the Director Placement Securities because the Securities will be issued on the same terms as those Securities issued to non-related party participants in the Placement and as such the giving of the financial benefit is on arm's length terms. 5.6 Additional information Resolution 3(a) - (b) are separate ordinary resolutions. The Board declines to make a recommendation in respect of Resolution 3(a) - (b) as a result of two Directors’ personal interest in the Resolutions. 6. Resolution 4 – Ratification of issue of Lead Manager Shares 6.1 Background The background to the Placement is in Section 3.1 above. Sixty Two Capital acted as lead manager to the Placement (Lead Manager), and, as consideration for the provision of lead manager services, the Company agreed to pay the Lead Manager a capital raising fee of 6% of the amount raised under the Placement (Capital Raising Fee) and 2,000,000 unquoted Options exercisable at $0.10 each and expiring 7 May 2024. As announced on 23 April 2024, Sixty Two Capital agreed to take up its Capital Raising Fee in Shares and Options issued on the same terms as the Placement, equating to 2,760,000 Shares and 1,380,000 unquoted Options. 6.2 General On 7 May 2024, the Company issued 2,760,000 Shares (